PLSE (Pulse Biosciences) Other Current Liabilities: $3.29 Mil (As of Mar. 2026)


PLSE Pulse Biosciences Inc PLSE
31 GF Score
Price $28.33
! 3 Warning Signs
View Full Analysis

What is Pulse Biosciences Other Current Liabilities?

Pulse Biosciences PLSE +2.16% 31 Other Current Liabilities is $3.29 Mil as of Mar. 2026. GuruFocus rates PLSE with a GF Score™ of 31/100. The stock has 3 warning signs investors should review.

Pulse Biosciences's other current liabilities for the quarter that ended in Mar. 2026 was $3.29 Mil.

Pulse Biosciences's quarterly other current liabilities declined from Sep. 2025 ($3.59 Mil) to Dec. 2025 ($1.98 Mil) but then increased from Dec. 2025 ($1.98 Mil) to Mar. 2026 ($3.29 Mil).

Pulse Biosciences's annual other current liabilities increased from Dec. 2023 ($3.20 Mil) to Dec. 2024 ($4.80 Mil) but then declined from Dec. 2024 ($4.80 Mil) to Dec. 2025 ($1.98 Mil).

Pulse Biosciences Other Current Liabilities Related Terms

Pulse Biosciences Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Pulse Biosciences's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pulse Biosciences Other Current Liabilities Chart

Pulse Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.93 1.38 3.20 4.80 1.98

Pulse Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.68 3.47 3.59 1.98 3.29
PLSE
31GF Score
Pulse Biosciences Inc PLSE
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pulse Biosciences Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $3.29 Mil mean?
Pulse Biosciences (PLSE) has a Other Current Liabilities of $3.29 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Pulse Biosciences.
Is Pulse Biosciences' Other Current Liabilities too high?
Pulse Biosciences' current Other Current Liabilities is $3.29 Mil. Overall, Pulse Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Pulse Biosciences' Other Current Liabilities compare to LMAT and XRAY?
Pulse Biosciences' Other Current Liabilities of $3.29 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Pulse Biosciences. Pulse Biosciences's current Other Current Liabilities is $3.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulse Biosciences stock overvalued right now?
Pulse Biosciences (PLSE) has a current Other Current Liabilities of $3.29 Mil. The current Other Current Liabilities is $3.29 Mil. Pulse Biosciences' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Pulse Biosciences (PLSE), the current Other Current Liabilities is $3.29 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pulse Biosciences Business Description

Other Exchanges 6L8:Germany
Address 601 Brickell Key Drive, Suite 1080, Miami, FL, USA, 33131
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
31GF Score

Get the complete analysis for PLSE

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.33
Price